Description
Buy BPC-157 Acetate + TB-500 Fragment 17-23 Online
BPC-157 Acetate + TB-500 Fragment 17-23 combines two research peptides associated with tissue repair, cellular migration, vascular signaling, and recovery pathways.
Product Information
BPC-157 is a synthetic pentadecapeptide investigated for cytoprotective and regenerative activity. TB-500 is associated with the N-terminally acetylated 17–23 sequence of thymosin beta-4, identified analytically as Ac-LKKTETQ.
How Does It Work?
The combination brings together BPC-157-associated repair signaling with thymosin-beta-4-fragment research involving cell migration and tissue-repair pathways.
Benefits
Supports Tissue Repair Research
BPC-157 has attracted extensive preclinical interest around tissue recovery, while the thymosin-beta-4 fragment provides an additional repair-focused pathway.
Recovery-Focused Peptide Combination
The blend targets multiple biological processes involved in tissue recovery rather than relying on a single peptide or mechanism.
Supports Vascular & Cellular Signaling
BPC-157 research has investigated angiogenesis and nitric-oxide-related pathways, while thymosin beta-4 research has focused heavily on cellular migration and repair.
Broad Musculoskeletal Research Potential
The combined profile makes this formulation particularly relevant to research involving muscle, tendon, connective tissue, and recovery processes.
Side Effects
Potential effects may include headache, nausea, fatigue, dizziness, injection-site reactions, and other unknown effects. Long-term human safety data for the combined formulation are lacking.
Dosage
There is no validated human dosing regimen for this specific blend. BPC-157 and the TB-500 fragment have not been established as a standardized combined therapy, so component dosing should not simply be added together.
Where to Buy BPC-157 Acetate + TB-500 Fragment 17-23
Purerawz does not sell or directly supply this blend. Where available, links may direct readers to independent third-party providers through affiliate relationships.
References
BPC-157 as an Investigational Peptide Therapeutic. Pharmaceutics. 2026;18(5):625.
PubMed — BPC-157 Investigational Review
Esposito S, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500. Drug Test Anal. 2012;4(9):733–738.
PubMed — TB-500 Fragment 17-23 Identification
Purerawz Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party suppliers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.
The information on these pages is provided for educational and informational purposes only. Dosage figures may reflect published research protocols or reported community use and should not be interpreted as personalized medical instructions. Research findings, particularly animal and early-stage studies, do not necessarily translate into established human benefits or safety.
Reviews
There are no reviews yet.